Adalimumab (anti-TNF-alpha)
Adalimumab (anti-TNF-alpha) is the first fully human, recombinant IgG1 monoclonal antibody that specifically targets human TNF-alpha, MW: 144.19 KD.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A2010 |
| Sku # | A2010-1mg*5 |
| Pricing | 1mg*5, $707.00 |
Citations for this product:
-
bioRxiv - Immunology 2022Quote: ... In adalimumab (A2010, Selleck Chemicals) studies ...
-
bioRxiv - Cell Biology 2023Quote: ... was added with or without simultaneous treatment with adalimumab (Selleck Chemicals A2010) or tofacitinib (Selleck Chemicals S2789) ...